StockVS

NYSE · Health Information Services · USD

Doximity, Inc. (DOCS) Stock Analysis

Doximity, Inc. (DOCS) is a Health Information Services stock listed on NYSE and quoted in US Dollar.

DOCS

$26.35

−$0.75 (−2.77%)

Sep 4, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare DOCS with… →

DOCS Key Statistics

As of Sep 4, 2026
Trading
Open
$26.77
Previous Close
$27.10
Day's Range
26.31–27.03
52-Week Range
17.15–76.51
Volume
1.98M
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
1.25
Valuation
Market Cap
$4.70B
P/E Ratio
32.13
Forward P/EShare price divided by forecast earnings for the year ahead, rather than the year just past.
17.01
PEG RatioThe P/E ratio divided by the expected earnings growth rate. It puts a high P/E in the context of how fast profits are growing.
0.59
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
7.16
EPS (ttm)Profit attributable to each share over the last twelve months.
0.82
Financials (FY)
Revenue (FY)
$644.86M+13.05%
Net Income (FY)
$196.05M−12.16%
Profit marginThe share of revenue left as profit after all costs and taxes.
25.48%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
127.35M
1-Year Return
−61.54%
Dividend and dates
Earnings Date
November 5, 2026estimated
Avg Volume
4.69M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

DOCS Stock Return by Calendar Year

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−40.49%
2025−17.06%
2024+90.41%
2023−16.45%
2022−33.05%
2021 (partial year)−5.42%

As of September 4, 2026.

DOCS Revenue and Earnings by Fiscal Year

FY ends March
Fiscal yearRevenueNet incomeNet margin
2025$644.86M$196.05M30.4%
2024$570.40M$223.19M39.1%
2023$475.42M$147.58M31.0%
2022$419.05M$112.82M26.9%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$644.86M$574.54M$214.92M$196.05M30.4%
2024$570.40M$514.53M$230.10M$223.19M39.1%
2023$475.42M$424.75M$171.81M$147.58M31.0%
2022$419.05M$365.56M$125.11M$112.82M26.9%

Annual figures as reported, in the company's reporting currency. As of March 31, 2026.

DOCS Valuation vs Health Information Services Median

Median of 53 stocks
MetricDOCSHealth Information Services medianvs median
P/E32.1341.1322% below
P/S ratio7.162.66169% above
Profit margin25.48%0.00%25.5 pts above

Medians across 53 Health Information Services stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of September 4, 2026.

Recent News

All 20 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

Doximity, Inc. (DOCS) carries a market capitalisation of $4.70B. It is classified in the Health Information Services industry, within the Healthcare sector. Headcount on file is 880.

The 52-week range on file runs from $17.15 to $76.51. DOCS last closed at $26.35 on September 4, 2026. That is −$0.75 (−2.77%) against the previous close. The latest close sits 53.64% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $644.86M. That is +13.05% against the prior fiscal year, when revenue was $570.40M. Net income for the same year was $196.05M. That is −12.16% against the prior fiscal year. Profit margin runs at 25.48%. That is 25.5 percentage points above the Health Information Services median of 0%. Earnings per share on a trailing basis come to 0.82.

Across the 4 fiscal years on file, revenue moves from $419.05M in 2022 to $644.86M in 2025. Of those 4 years, 4 report positive net income.

Valuation Assessment

DOCS trades at a trailing price-to-earnings ratio of 32.13. That is 21.88% below the Health Information Services median of 41.13. The forward P/E on file is 17.01. The PEG ratio, which sets the P/E against expected earnings growth, reads 0.59. Measured against sales, the shares trade at 7.16 times revenue. On price-to-sales that is 169.46% above the Health Information Services median of 2.66. The medians here are taken across 53 Health Information Services companies that report the metric.

The reported beta is 1.25. Annualized volatility over the trailing 5 years is 66.65%. The trailing one-year price return is −61.54%. Measured over 5 years, that is −23.28% a year compounded.

Growth & Income

No dividend is on file for DOCS.

2026 is still running; the price is −40.49% year to date. The strongest complete calendar year on file is 2024 at +90.41%; the weakest is 2022 at −33.05%. Of the 4 complete calendar years on file, 1 finished higher.

Peer Comparison

Doximity, Inc. (DOCS) operates in the Health Information Services industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Doximity, Inc. DOCS $4.70B 32.1
Veeva Systems Inc. VEEV $44.54B 45.0
BrightSpring Health Services, Inc. BTSG $12.02B 54.7
Tempus AI, Inc. TEM $11.66B

The Health Information Services industry average P/E ratio is 41.1x. Doximity, Inc. trades at a P/E of 32.1.

Every figure above is read from this page's own data on each nightly rebuild. Informational only, not financial advice. As of September 4, 2026.

Related Health Information Services Stocks

View all Health Information Services stocks →

Popular Healthcare Stocks

View all Healthcare stocks →

About Doximity, Inc.

Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Visit website →